Life Science Omics Tools/MDx Stocks Inch up in July | GenomeWeb

NEW YORK (GenomeWeb) – Life science omics tools and molecular diagnostics stocks eked out a small gain in July lifted by the relative strength of the broader biotechnology space. 

The GenomeWeb Index rose a fraction of 1 percent compared to June, as 17 companies saw gains in their share prices while 15 firms saw declines in their stocks. The index beat the Dow Jones Industrial Average, which improved a fraction of 1 percent, but it trailed the Nasdaq, which was up about 3 percent, and the Nasdaq Biotech Index, which grew almost 4 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.